Company Filing History:
1 out of 4 
1 out of 34 
1 out of 42 
Years Active: 2021
Title: Seung Ryul I Han: Innovator in Cancer Treatment
Introduction
Seung Ryul I Han is a prominent inventor based in Yongin-si, South Korea. He has made significant contributions to the field of cancer research through his innovative work on ribozymes. His dedication to advancing medical science has led to the development of a unique patent that holds promise for cancer treatment.
Latest Patents
One of Seung Ryul I Han's notable patents is titled "Cancer-specific trans-splicing ribozymes and use thereof." This invention focuses on a trans-splicing ribozyme that specifically targets cancer tissue while sparing normal tissue. The ribozyme demonstrates excellent expression efficiency at the post-transcription level, making it a safe and effective option for cancer treatment. With 1 patent to his name, his work is paving the way for new therapeutic approaches in oncology.
Career Highlights
Throughout his career, Seung Ryul I Han has been associated with reputable organizations such as Rznomics Inc. and the Dong-a University Research Foundation for Industry-Academy Cooperation. His experience in these institutions has allowed him to collaborate with other experts in the field and further his research endeavors.
Collaborations
Seung Ryul I Han has worked alongside notable colleagues, including Seong-Wook Lee and Chang Ho Lee. Their combined expertise has contributed to the advancement of innovative solutions in cancer treatment.
Conclusion
Seung Ryul I Han's contributions to cancer research through his innovative patent highlight his commitment to improving patient outcomes. His work exemplifies the potential of targeted therapies in the fight against cancer.